Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery

NCT04773093 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Craniotomy Tumor Removal Surgery

Interventions

DRUG: Continous Intravenous Lidocaine Infusion
DRUG: Placebo

Sponsor

Indonesia University